Literature DB >> 11009318

The evolution of antibiotic therapy for bacterial conjunctivitis and keratitis: 1970-2000.

J Baum1, M Barza.   

Abstract

The editors of this Festschrift asked us to review the use of antibiotics for the treatment of bacterial conjunctivitis and keratitis over the past 25 years, a period coinciding with the life of the Castroviejo Corneal Society. We believe it is more appropriate to begin our review in the late 1960s. about the time that experimental and clinical studies and algorithms for the clinical care derived from these studies helped shape a more rigorous approach to therapy. Those years saw the introduction of antibiotics that were adapted for ophthalmic use, many of which are still being used today. We will give more weight to our review of keratitis than conjunctivitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11009318     DOI: 10.1097/00003226-200009000-00011

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  13 in total

1.  Shifting trends in in vitro antibiotic susceptibilities for common bacterial conjunctival isolates in the last decade at the New York Eye and Ear Infirmary.

Authors:  Adebukola Adebayo; Jignesh G Parikh; Steven A McCormick; Mahendra K Shah; Remedios S Huerto; Guopei Yu; Tatyana Milman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-06-08       Impact factor: 3.117

2.  Orlans HO, Hornby SJ, Bowler IC (2011) In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review. Eye Jan 21 [Epub ahead of print] PMID 21252952.

Authors:  Stephen Kaye; Rose Gilbert; Henri Sueke; Timothy Neal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-03-29       Impact factor: 3.117

3.  Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis.

Authors:  Prajna Lalitha; Muthiah Srinivasan; P Manikandan; M Jayahar Bharathi; Revathi Rajaraman; Meenakshi Ravindran; Vicky Cevallos; Catherine E Oldenburg; Kathryn J Ray; Christine M Toutain-Kidd; David V Glidden; Michael E Zegans; Stephen D McLeod; Nisha R Acharya; Thomas M Lietman
Journal:  Clin Infect Dis       Date:  2012-03-23       Impact factor: 9.079

Review 4.  Corneal ulceration in pediatric patients: a brief overview of progress in topical treatment.

Authors:  Serina Stretton; Usha Gopinathan; Mark D P Willcox
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

5.  The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis.

Authors:  Jose Benitez-Del-Castillo; Yves Verboven; David Stroman; Laurent Kodjikian
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

6.  Bacterial keratitis: perspective on epidemiology, clinico-pathogenesis, diagnosis and treatment.

Authors:  Abdullah Al-Mujaini; Nadia Al-Kharusi; Archana Thakral; Upender K Wali
Journal:  Sultan Qaboos Univ Med J       Date:  2009-06-30

7.  Severe infective keratitis leading to hospital admission in New Zealand.

Authors:  T Wong; S Ormonde; G Gamble; C N J McGhee
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

Review 8.  Ocular infections due to anaerobic bacteria.

Authors:  I Brook
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

9.  Antimicrobial Susceptibility Patterns and Resistance Trends of Staphylococcus aureus and Coagulase-Negative Staphylococci Strains Isolated from Ocular Infections.

Authors:  Francesco Petrillo; Danilo Pignataro; Federica Maria Di Lella; Michele Reibaldi; Matteo Fallico; Niccolò Castellino; Guglielmo Parisi; Maria Consiglia Trotta; Michele D'Amico; Biagio Santella; Veronica Folliero; Maria Teresa Della Rocca; Michele Rinaldi; Gianluigi Franci; Teresio Avitabile; Marilena Galdiero; Giovanni Boccia
Journal:  Antibiotics (Basel)       Date:  2021-05-03

10.  A European perspective on topical ophthalmic antibiotics: current and evolving options.

Authors:  D Bremond-Gignac; F Chiambaretta; S Milazzo
Journal:  Ophthalmol Eye Dis       Date:  2011-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.